Caina Technology Co

Caina Technology Co EBIT/Assets

The Operating Income to Assets Ratio (EBIT/Assets) of Caina Technology Co (301122.SZ) as of Oct 16, 2026 is 0.16 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was 2.90 % — a change of -94.47% (lower).

EBIT/Assets

0.16 %

YoY

-94.47%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of Caina Technology Co is 2025 0.16 % . Operating Income to Assets Ratio (EBIT/Assets) of Caina Technology Co was 2024 2.90 % . It decreases by -94.47% lower compared to the previous year.

The Caina Technology Co EBIT/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT/Assets
Date
EBIT/Assets
Jan 1, 2018
8.18 CNY
Jan 1, 2019
14.22 CNY
Jan 1, 2020
34.23 CNY
Jan 1, 2021
24.79 CNY
Jan 1, 2022
9.76 CNY
Jan 1, 2023
6.71 CNY
Jan 1, 2024
2.90 CNY
Jan 1, 2025
0.16 CNY
The Caina Technology Co EBIT/Assets history
YEAREBIT/AssetsYoY
0.16 %-94.47%
2.90 %-56.79%
6.71 %-31.20%
9.76 %-60.64%
24.79 %-27.58%
34.23 %+140.78%
14.22 %+73.87%
8.18 %+30.79%
6.25 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Caina Technology Co Stock analysis

What does Caina Technology Co do? Caina Technology Co Ltd is a company based in Wuxi, China, operating within the Health Care sector. The company went public on January 26, 2022, with its stock ticker 301122.SZ and ISIN CNE1000056T2. It employs 689 full-time staff and focuses on manufacturing medical consumables. Caina Technology's product range includes puncture needles, syringes, laboratory consumables, and masks. Specific products mentioned are reusable copper base injection needles, aluminum base injection needles, disposable aluminum-plastic inlaid injection needles, safety blood collection needles, sheathed syringes, disposable sterile syringes, petri dishes, and reagent tubes. The company exports its products to the United States, the United Kingdom, the European Union, and other international markets. Its website is http://www.caina.ltd/. Caina Technology is engaged in the production of medical consumables, with a focus on a variety of needles, syringes, and laboratory equipment. The company's operations are centered in Wuxi, Jiangsu Province, and it serves both domestic and international clients through its export channels. Caina Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Caina Technology Co stock

Operating Income to Assets Ratio (EBIT/Assets) of Caina Technology Co is 0.16 % in 2025.

Operating Income to Assets Ratio (EBIT/Assets) of Caina Technology Co changed from 2.90 % to 0.16 %, representing a -94.47% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) Caina Technology Co since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s Caina Technology Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Caina Technology Co

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Caina Technology Co